论文部分内容阅读
目的观察黄芪注射液辅助抗结核药治疗肺结核的临床疗效。方法将60例肺结核患者随机分为两组,对照组30例,治疗组30例。对照组单独使用抗结核西药治疗,治疗组在对照组治疗的基础上,加用黄芪注射液静脉滴注。比较两组患者痰菌阴转、病变吸收不良反应等情况。结果治疗组痰菌阴转率为98.8%,对照组93.8%;治疗组病变总吸收率为90.4%,对照组78.8%;治疗组不良反应发生率为7.2%,对照组18.8%。两组比较,差异皆有统计学意义(P<0.05)。结论黄芪注射液与抗结核药联合治疗肺结核,疗效显著,有利于抗结核治疗疗程的顺利进行,可提高治愈率,降低抗结核药物的不良反应。
Objective To observe the clinical efficacy of Astragalus injection assisted with anti-tuberculosis drugs in the treatment of pulmonary tuberculosis. Methods Sixty patients with pulmonary tuberculosis were randomly divided into two groups: control group (30 cases) and treatment group (30 cases). The control group was treated with anti-TB western medicine alone, and the treatment group was treated with intravenous infusion of Astragalus injection on the basis of the treatment of the control group. The two groups of patients sputum negative conversion, adverse reactions and other changes in absorption. Results The sputum negative conversion rate was 98.8% in the treatment group and 93.8% in the control group. The total absorption rate of the treatment group was 90.4% and that of the control group was 78.8%. The incidence of adverse reactions in the treatment group was 7.2% and that in the control group was 18.8%. The differences between the two groups were statistically significant (P <0.05). Conclusion Astragalus injection and anti-tuberculosis drugs combined treatment of pulmonary tuberculosis, significant effect, is conducive to the smooth progress of anti-TB treatment can improve the cure rate and reduce the adverse reactions of anti-TB drugs.